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Abstract 
Vitamin D is a hormone, produced endogenously through cutaneous transformation 
of 7-dehydrocholesterol by UVB-irradiation with skeletal and non-skeletal functions 
and could be involved in oral health conditions especially periodontitis. Vitamin D 
main mechanism of action occurs through binding to its intracellular receptor. In this 
article, we aim to review the beneficial role of vitamin D in dentistry. Articles related 
to vitamin D and oral health were screened and reviewed with the main findings and 
clinical implications presented. Vitamin D deficiency prevalence is high especially 
among the elderly and is associated with oral health complications such as 
periodontitis with a possible role of vitamin D supplementation in oral health 
conditions’ management. The review discusses the main findings as although the 
majority of the literature demonstrates vitamin D essential role, some research 
suggest excess vitamin D supplementation could lead to other health issues. Thus, 
further research is needed to define vitamin D target levels and establish effective 
strategies for managing patients suffering from oral health conditions especially 
periodontitis. Improving the knowledge of dental practitioners, periodontologists and 
pharmacists regarding vitamin D deficiency implications in oral health conditions 
could guide the management of oral conditions especially periodontitis. 
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Introduction 
Vitamin D is a fat-soluble hormone with endocrine and autocrine functions 
(Razzaque, 2018) and could be obtained through absorption or ultraviolet irradiation 
(Powers and Gilchrest, 2012). Vitamin D is then activated through hydroxylation 
process in the liver and kidney to produce the active hormone 1,25(OH)2D (Powers 
and Gilchrest, 2012). The active hormone acts as a signalling molecule and an 
essential factor of calcium and phosphorus homeostasis for bony tissue growth 
(Slebioda et al., 2016). 1,25(OH)2D is also involved in essential life processes such 
as proliferation, differentiation, apoptosis, immune and hormonal regulation (Radlovic 
et al., 2012). Several factors could reduce vitamin D synthesis such as sun 
avoidance practices, sun protection creams and melanin in skin (Macdonald, 2013). 
These factors could increase the risk of vitamin D deficiency, a major global health 
issue affecting more than one billion person worldwide and leading to health 
conditions such as pre-eclampsia, childhood dental caries, periodontitis, 
cardiovascular and neurological disorders (Holick, 2017). As periodontitis is 
considered an inflammatory condition caused by the imbalance between the 
virulence factors produced by microorganisms and the inflammatory host response, 
appreciating the role of vitamins especially vitamin D in modulating the immune 
system is of primary importance. Other risk factors for periodontal disease 
progression include smoking, diabetes, obesity and steroids (Goyal et al., 2017). 
In this review, we aim to review the current developments in our understanding of 
vitamin D pharmacology and how vitamin D deficiency could influence the 
pathogenesis of oral conditions such as periodontitis. Research articles were 
reviewed after a comprehensive search using the Medline (PubMed) for the following 
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MESH terms “dental and vitamin D”, “Oral health and vitamin D” and “Oral disorders 
and vitamin D”. 
Vitamin D Pharmacology 
Vitamin D main target is the ubiquitously expressed nuclear vitamin D receptor 
(VDR) (Radlovic et al., 2012), which is a regulator of insulin, aromatase and 
osteocalcin (Boisen et al., 2017). 1,25(OH)2D affect receptor activator of nuclear 
factor κB ligand (RANKL) expression (Nakamichi and Takahashi, 2015; Takahashi, 
2013) and regulate fibroblast growth factor 23 (FGF23) - a bone-derived hormone 
(Bhattacharyya et al., 2012; Nakamura et al., 2009). RANKL is one of two cytokines 
expressed by osteoblasts and involved in bone marrow macrophages differentiation 
into osteoclasts (Mizoguchi, 2011) alongside constitutively macrophage-colony 
stimulating factor (M-CSF) (Nakamichi et al., 2018). Osteoblasts acts as regulatory 
cells to control calcium homeostasis, where rapid non-genomic actions include 
activation of voltage-sensitive Ca2+ channels, elevation of intracellular Ca2+ 
concentrations, induction of phospholipid turnover and activation of second 
messenger systems. Longer term actions of vitamin D binding to its nuclear 
receptors include target genes transcription such as the genes coding bone matrix 
proteins (Farach-Carson and Ridall, 1998). Vitamin D also interacts with calcium-
binding proteins such as calbindin and osteocalcin with a role in dentinogenesis and 
amelogenesis (Berdal et al., 1995; Berdal et al., 1989).  
This interaction alters the renal calcium and phosphate reabsorption (Razzaque, 
2012) with dental matrix protein-1, an osteocyte product, participating in FGF23-
mediated regulation of phosphorus homeostasis (Civitelli and Ziambaras, 2011). 
Vitamin D possesses other non-calcaemic actions such as anti-proliferative, pro-
differentiative and immunomodulatory activities (Nagpal et al., 2001). VDR was 
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discovered in several immunological cells such as T-, B- lymphocytes, macrophages, 
mast cells and regulatory T cells (Tregs); while vitamin D acts as a regulator of 
immune function by suppressing inflammatory cytokines such as tumour necrosis 
factors (TNF) and interferon gamma and stimulating anti-inflammatory cytokines 
generation (Figure 1) (Toniato et al., 2015). VDR genetic polymorphisms plays an 
important role in the pathogenesis of several conditions such as external apical root 
resorption and permanent loss of dental root structure (Nieto-Nieto et al., 2017) and 
there is association between VDR polymorphisms and fluorosis susceptibility pattern 
(Pramanik and Saha, 2017). VDR polymorphisms were also involved in periodontal 
disease through changes in bone mineral density or immunomodulatory effects 
(Martelli et al., 2014; Amano et al., 2009). Another study highlighted the association 
of VDR polymorphisms with aggressive and chronic periodontitis in a Taiwanese 
population (Ho et al., 2017), while a recent meta-analysis in Chinese population 
showed that VDR TaqI polymorphism was not associated with periodontitis risk, 
raising the need for further research in this field (Ji et al., 2016). 
Deficiency of vitamin D and Oral disorders: 
Teeth are mineralized organs composed of three hard tissues: enamel, dentin and 
cementum, while supported by the surrounding alveolar bone. Various oral diseases 
such as metabolic bone diseases - disorders of bone remodelling - often first 
diagnosed from abnormalities in the oral cavity or on dental radiographs 
(Zachariasen, 1990) could result from inadequate vitamin D level (Uwitonze et al., 
2018). Low bone-mineral density could occur in alveolar bone and people with 
osteoporosis could suffer from increased risk of tooth loss (Stewart and Hanning, 
2012), while rickets’ sufferers possessed defective dentition (Foster et al., 2014), 
poor development and calcification of the alveolus leading to loss of lamina dura and 
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periodontal ligament with defects in the dentinoenamel junction and cementum 
(Cohen and Becker, 1976). X-linked hypophosphataemic (XLH) rickets sufferers 
have decreased renal phosphate reabsorption, hypophosphatemia and inappropriate 
vitamin D levels with abnormally high pulp volume/tooth volume ratio, thin enamel 
and spontaneous dental abscesses without any signs of dental caries or trauma 
(Sabandal et al., 2015; Kienitz et al., 2011; Seow, 2003). Patients with rickets-like 
genetic diseases such as pycnodysostosis also show obtuse mandibular angle and 
dental abnormalities (Ma, 2013).  
Osteoporosis is a common disease in middle aged post-menopausal women with 
bone weakness affecting the ridges holding dentures leading to need of new 
dentures and continued teeth loss (Bandela et al., 2015; Faine, 1995). Several 
studies confirmed the correlation between osteoporosis and alveolar bone loss in 
periodontal disease (Loza et al., 1996). At the pharmacological concentration, 
vitamin D could be used in osteoporosis management (Nakamichi et al., 2018) and 
supporting tooth retention (Krall, 2006).  
Other clinical conditions associated with vitamin D deficiency such as 
hypophosphatasia are characterized by defective mineralization of bone and/or teeth 
with premature exfoliation of primary teeth, dry mouth, multiple dental caries and 
abnormal morphology (Geng et al., 2018).  Calcium and vitamin D supplements 
should be also considered in Rothmund-Thomson syndrome, characterized by 
skeletal and dental abnormalities (Wang and Plon, 2019). Vitamin D could reduce 
orthodontic treatment time with advantages including reduction in predisposition to 
caries, gingival recession and root resorption (Nimeri et al., 2013).  
Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse drug 
reaction leading to the progressive bone destruction in the maxillofacial region, 
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caused by antiresorptive medications such as bisphosphonates (Rosella et al., 
2016). Osteoclast inhibitors such as denosumab; used in patients with bone 
metastases; could lead to jaw osteonecrosis (1.8%) and hypocalcaemia (9.6%); 
where calcium and vitamin D supplementation with good oral hygiene and regular 
dental reviews are required (Domschke and Schuetz, 2014; Vescovi and Nammour, 
2010; Pittman et al., 2017) (Table 1).  
Vitamin D and periodontitis/ peri-implant diseases  
Increasing evidence connect low vitamin D serum levels and gingival inflammation 
(Stein et al., 2014), while severe periodontal disease could occur with low dietary 
calcium and vitamin D (Genco and Borgnakke, 2013). Scientific results have shown 
that vitamin D supplementation could reduce rate of alveolar bone loss (Intini et al., 
2014). On the other hand, other studies highlighted the association between 
elevated plasma vitamin D levels with aggressive periodontitis (Liu et al., 2009), 
while initial periodontal therapy reduced systemic vitamin D significantly (Liu et al., 
2010) (Table 1). The same research group demonstrated expression of 1alpha-
hydroxylase in human gingival fibroblasts and periodontal ligament cells tissue  
cultures  (Liu et al., 2012) and that vitamin D induced cationic antimicrobial protein 
expression, an effect reduced by blocking VDR (Gao et al., 2018). Other researchers 
showed vitamin D role in stimulating the antibacterial defence of gingival cells 
(McMahon et al., 2011), further supporting vitamin D actions on the immune system 
in periodontal tissues. 
Osseointegration-based dental implants success depends on the stable integration 
and maintenance of implant fixtures in alveolar bone with complex molecular 
pathways involving vitamin D (Nishimura, 2013) and a prominent role of osteocytes 
and immune cells in dental implant osseointegration and maintenance (Insua et al., 
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2017). Vitamin D deficiency slows implant osseointegration and increases the risk of 
graft infection (Choukroun et al., 2014). Thus it is recommended that following 
implant fixation, medications to enhance osseointegration such as vitamin D should 
be given (Apostu et al., 2017) (Table 1).  
Vitamin D and paediatric oral health 
Clinical trials identified vitamin D as a promising caries-preventive agent (Hujoel, 
2013) with clear association between maternal vitamin D concentrations at term and 
paediatric dental caries (Theodoratou et al., 2014) as low prenatal or maternal 
vitamin D levels could lead to enamel defects (Berdal et al., 2000) and detrimental 
effect on bone and teeth development, while vitamin D supplementation during 
pregnancy was associated with reduction in the risk of infancy dental caries (Karras 
et al., 2016) (Table 1).  
Discussion 
Vitamin D is produced photochemically from its provitamin, 7-dehydrocholesterol 
(Davies, 1989) with an important role in regulating calcium and maintaining healthy 
teeth (Rowe, 2004). Vitamin D influences phosphate co-transporters in the intestine 
and kidney, thus affecting phosphate balance (Ohnishi and Razzaque, 2013). 
Vitamin D is metabolised by a hepatic 25-hydroxylase into 25-hydroxyvitamin D and 
by a renal 1alpha-hydroxylase into 1,25(OH)2D (Zittermann, 2003).  Vitamin D has 
immunomodulatory and anti-inflammatory properties (Jeffery et al., 2016), supporting 
its beneficial oral health effects through direct effect on bone metabolism (Stein et 
al., 2014) as calbindins and alkaline phosphatase handling proteins - affecting 
calcium and phosphate balance- are present in dental mineral tissues (Berdal et al., 
2000).  
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The prevalence of vitamin D deficiency is increasing worldwide (Wimalawansa et al., 
2018) and associated with oral health disorders such as dental caries and 
periodontal disease (Uwitonze et al., 2018). The most advantageous vitamin D 
serum levels for dental health are 75 nmol/l (30 ng/ml) with 800 IU (20 microg) of 
cholecalciferol administration per day needed (Bischoff-Ferrari, 2014) and even 
higher oral doses (1,800 to 4,000 IU) could be used (Bischoff-Ferrari et al., 2010). 
Periodontitis is characterized by bone resorption, local inflammatory bone loss and 
tooth loss with osteoporosis as a risk factor; some evidence describes vitamin D 
supplementation as a concomitant management (Wang and McCauley, 2016), while 
other evidence highlighted an association between elevated plasma vitamin D and 
aggressive periodontitis with a role of vitamin D in stimulating the antibacterial 
defence of gingival cells (McMahon et al., 2011; Liu et al., 2012). 
Residents of long-term care facilities are considered at high risk for oral health 
conditions as they often lack basic dental care with unnecessary tooth loss, 
periodontal disease (Wick, 2010) and prevalence of vitamin D insufficiency 
(Nakamura, 2006) and individuals with neurodevelopmental disorders, intellectual 
disabilities and eating disorders generally have low vitamin D and adequate 
calcium/vitamin D supplementation is recommended (Drabkin et al., 2017) in those 
risk groups with careful medication monitoring to prevent tooth loss, combat caries 
and decrease periodontal disease (Grant et al., 2015). Clinicians have an important 
role as many inherited disorders have oral manifestations detected by dental 
radiographs (Witkop, 1976) to optimise vitamin D levels (Leizaola-Cardesa et al., 
2016) especially in periodontitis (Palacios et al., 2009). Clinicians should be cautious 
as prolonged/ disproportionate consumption of vitamin D may lead to intoxication, 
even without clear signs of hypervitaminosis D (Razzaque, 2018; Ballmer, 1996). 
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Although, oral vitamin D intakes up to 250 μg/day have not been associated with 
harm (Zittermann et al., 2013), clinicians should avoid recommending high serum 
concentrations (Sanders et al., 2013) especially that the routine use of intermittent 
vitamin D high-dose was associated with increased risk of falls or fractures (Choi et 
al., 2017) and tissue/ organ damages (Razzaque, 2018).  
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Figure 1: Pharmacology of Vitamin D  
 
 
Vitamin D major mechanisms of action through its interaction with VDR. This interaction affects 
calcium/phosphates absorption, bone marrow differentiation to osteoclasts, phosphate secretion, 
cytokines production and amelogenesis/dentinogenesis through cellular signalling molecules such as 
RANKL and FGF 23. 
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Table 1: Vitamin D and Oral Health Care  
Condition Summary of findings regarding vitamin D (as 
per current clinical research) 
Defective dentition/metabolic 
bone diseases 
Possible role for vitamin D supplementation in 
management of these conditions. 
Osteoporosis Vitamin D supplementation is considered as a 
recommended management. 
Medication-related 
osteonecrosis of the jaw 
Vitamin D supplementation is recommended, further 
clinical studies are needed. 
Periodontitis Low calcium and vitamin D lead to periodontal 
disease, however, some studies highlighted 
association of elevated vitamin D levels with 
aggressive periodontitis - further studies needed. 
Dental implant success Vitamin D deficiency slows implant osteointegration 
and increase risk of graft rejection - medications to 
enhance osseointegration such as vitamin D should 
be given following implant fixation.  
Paediatric caries Vitamin D is considered a promising caries 
preventive agent. 
 
 
